| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39bf0bb8b07e151d4bcead749d7dd699 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-3156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-646
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-09 |
| filingDate |
2008-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18d99619487280642763c6e61b8d3fdc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18e2b9743b3158f81e00e430160e040e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a0b89b452326bb0ba32d26ed2e5dfdd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4847151d07b9aea25c590d3424e7fdcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8355e7c903491161b3bcc39fd5326e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d94c3c63f6a201cce13f153a33644988 |
| publicationDate |
2016-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2580957-T3 |
| titleOfInvention |
Compositions comprising pneumococcal antigens |
| abstract |
An immunogenic composition comprising a combination of S. pneumoniae antigens, said combination comprising a spr0096 antigen and a spr2021 antigen, wherein: said spr0096 antigen is a polypeptide comprising an amino acid sequence: (a) having an identity of 80% or higher with SEQ ID NO: 12; and / or (b) comprising a fragment of at least 10 consecutive amino acids, comprising an epitope of SEQ ID NO: 12; and said spr2021 antigen is a polypeptide comprising an amino acid sequence: (a) having an identity of 80% or greater with SEQ ID NO: 11; and / or (b) comprising a fragment of at least 10 consecutive amino acids, comprising an epitope of SEQ ID NO: 11. |
| priorityDate |
2007-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |